Full Length Research Paper
References
| Abubakar E (2009). Efficacy of crude extracts of garlic (Allium sativum Linn.) against nosocomial Escherichia coli, Staphylococcus aureus, Streptococcus pneumoniae and Pseudomonas aeruginosa. J. Med. Plant Res. 3:179-185. | ||||
|
Ankri S, Mirelman D (1999). Antimicrobial properties of allicin from garlic. Microbes Infect. 1: 125-129. Crossref |
||||
|
Auer S, Wojna A, Hell M (2010). Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. Antimicrob. Agents Chemother. 54:4006-4008. Crossref |
||||
|
Banerjee SK, Maulik SK (2002). Effect of garlic on cardiovascular disorders: a review. Nutr. J. 1:4. Crossref |
||||
|
Baral R, Timilsina S, Jha P, Bhattarai NR, Poudyal N, Gurung R, Khanal B, Bhattachary SK (2013). Study of antimicrobial susceptibility pattern of Gram positive organisms causing UTI in a tertiary care hospital in eastern region of Nepal. Health Renaiss. 11:119-124. Crossref |
||||
|
Bodini SF, Manfredini S, Epp M, Valentini S, Santori F (2009). Quorum sensing inhibition activity of garlic extract and p-coumaric acid. Lett. Appl. Microbiol. 49(5):551-555. Crossref |
||||
| Bokaeian M, Bameri Z (2013). In vitro antibacterial properties of aqueous garlic extract against multidrug-resistant enterococci. Zahedan J. Res. Med. Sci. 15:43-49. | ||||
|
Bouza E, San Juan R, Munoz P, Voss A, Kluytmans J (2001). Co-operative group of the European study group on nosocomial infections. A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGNI- 004 study). European study group on nosocomial infections. Clin. Microbiol. Infect. 7:532–542. Crossref |
||||
|
Butt T, Leghari MJ, Mahmood A (2004). In-vitro activity of nitrofurantoin in Enterococcus urinary tract infection. J. Pak. Med. Assoc. 54: 466-469. Pubmed |
||||
|
Cai Y, Wang R, Pei F, Liang BB (2007). Antibacterial activity of allicin alone and in combination with β -lactams against Staphylococcus spp. and Pseudomonas aeruginosa. J. Antibiot. 60: 335–338. Crossref |
||||
|
Cetti RJ, Venn S, Woodhouse CR (2009). The risks of long-term ni-trofurantoin prophylaxis in patients with recurrent urinary tract infection: A recent medico-legal case. BJU Int. 103: 567-569. Crossref |
||||
| Chaudhary U, Aggarwal R (2004). Extended spectrum-lactamases (ESBL) - An emerging threat to clinical therapeutics. Ind. J. Med. Microbiol. 22: 75-80. | ||||
| Chayakul P, Hortiwakul R, Ingviya N, Chayakul V (2007). Species distribution and antimicrobial susceptibility of enterococci in hospitalized patients in Southern Thailand. J. Infect. Dis. Antimicrob. Agents 24: 49-54. | ||||
|
Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF, Melton DM, Beachey EH (1985). Adherence of coagulase negative Staphylococci to plastic tissue cultures: a quantitative model for the adherence of Staphylococci to medical devices. J. Clin. Microbiol. 22: 996-1006. Pubmed |
||||
| Clinical and Laboratory Standards Institute, CLSI (2013). Performance standards for antimicrobial susceptibility testing; Twenty-third infor-mational supplement. CLSI document M100-S23. CLSI, Wayne, PA. | ||||
|
Comerlato CB, de Resende MC, Caierão J, d'Azevedo PA (2013). Presence of virulence factors in Enterococcus faecalis and Enterococcus faecium susceptible and resistant to vancomycin. Mem. Inst. Oswaldo Cruz 108: 590-595. Crossref |
||||
|
Costerton JW, Stewart PS, Greenberg EP (1999). Bacterial biofilms: A common cause of persistent infections. Science 284: 1318-1322. Crossref |
||||
|
Das T, Choudhury AR, Sharma A, Talukder G (1996). Effects of crude garlic extract on mouse chromosomes in vivo. Food Chem. Toxicol. 34: 43-47. Crossref |
||||
|
Ejrnæs K (2011). Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli. Dan. Med. Bull. 58: B4187. Pubmed |
||||
|
Flemming K, Klingenberg C, Cavanagh JP, Sletteng M, Stensen W, Svendsen JS, Flægstad T (2009). High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms. J. Antimicrob. Chemother. 63: 136 - 145. Crossref |
||||
| Ghanwate NA (2012). Biofilm eradication studies on uropathogenic E. coli using ciprofloxacin and nitrofurantoin. Int. J. Pharm. Biomed. Res. 3: 127-131. | ||||
|
Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE (2011). International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Micro-biology and Infectious Diseases. Clin. Infect. Dis. 52: e103-e120. Crossref |
||||
|
Hancock V, Dahl M, Klemm P (2010). Abolition of biofilm formation in urinary tract Escherichia coli and Klebsiella isolates by metal interference through competition for fur. Appl. Environ. Microbiol. 76: 3836-3841. Crossref |
||||
|
Hassan A, Usman J, Kaleem F, Omair M, Khalid A, Iqbal M (2011). Evaluation of different detection methods of biofilm formation in the clinical isolates. Braz. J. Infect. Dis. 15: 305-311. Crossref |
||||
| Hindi NK (2013). In vitro antibacterial activity of aquatic garlic extract, apple vinegar and apple vinegar-garlic extract combination. Am. J. Phytomed. Clin.Therapeutics 1:42-51. | ||||
| Isenberg HD (2007). Clinical Microbiology Procedures Handbook. Vol. II, Second edition, ASM Press, Washington, DC, USA. | ||||
|
Iwalokun BA, Ogunledun A, Ogbolu DO, Bamiro SB, Jimi-Omojola J (2004). In vitro antimicrobial properties of aqueous garlic extract against multidrug-resistant bacteria and Candida species from Nigeria. J. Med. Food 7: 327-333. Crossref |
||||
|
Jakobsen TH, van Gennip M, Phipps RK, Shanmugham MS, Christensen LD, Alhede M, Skindersoe ME, Rasmussen TB, Friedrich K, Uthe F, Jensen PØ, Moser C, Nielsen KF, Eberl L, Larsen TO, Tanner D, Høiby N, Bjarnsholt T, Givskov M (2012). Ajoene, a sulfur-rich molecule from garlic, inhibits genes controlled by quorum sensing. Antimicrob. Agents Chemother. 56:2314-2325. Crossref |
||||
|
Jonkers D, Sluimer J, Stobberingh E (1999). Effect of garlic on vancomycin-resistant enterococci. Antimicrob. Agents Chemother. 43: 3045. Pubmed |
||||
|
Karlowsky JA, Lagace´-Wiens PR, Simner PJ, DeCorby MR, Adam HJ, Walkty A, Hoban DJ, Zhanel GG (2011). Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: Canward surveillance study. Antimicrob. Agents Chemother. 55:3169–3175. Crossref |
||||
|
Karpman E, Kurzrock EA (2004). Adverse reactions of nitrofurantoin, trimethoprim and sulfamethoxazole in children. J. Urol. 172:448-453. Crossref |
||||
|
Kouidhi B, Zmantar T, Mahdouani K, Hentati H, Bakhrouf A (2011). Antibiotic resistance and adhesion properties of oral Enterococci associated to dental caries. BMC Microbiol. 11:155-161. Crossref |
||||
|
Lee HJ, Park HS, Kim KH, Kwon TY, Hong SH (2011). Effect of garlic on bacterial biofilm formation on orthodontic wire. Angle Orthod. 81:895-900. Crossref |
||||
|
Marra A, Dib-Hajj F, Lamb L, Kaczmarek F, Shang W, Beckius G, Milici AJ, Medina I, Gootz TD (2007). Enterococcal virulence determinants may be involved in resistance to clinical therapy. Diag. Micr. Infec. Dis. 58:59–65. Crossref |
||||
|
Mukherjee M, Basu S, Mukherjee SK, Majumder M (2013). Multi-drug resistant and extended-spectrum beta-lactamase production in uropathogenic E. coli which were isolated from hospitalized patients in Kolkata, India. J. Clin. Diagn. Res. 7: 449-453. Pubmed |
||||
| Nataro J, Bopp C, Fields P, Kaper J, Strockbine N (2011). Escherichia, Shigella, and Salmonella. In Versalovic et al. (eds) Manual of Clinical Microbiology. 10th edition. ASM Press, Washington DC, USA. pp. 603 - 606. | ||||
|
Norinder BS, KÙves B, Yadav M, Brauner A, Svanborg C (2012). Do Escherichia coli strains causing acute cystitis have a distinct virulence repertoire? Microb. Pathog. 52: 10-16. Crossref |
||||
|
Novais Â, Vuotto C, Pires J, Montenegro C, Donelli G, Coque TM, Peixe L (2013). Diversity and biofilm-production ability among isolates of Escherichia coli phylogroup D belonging to ST69, ST393 and ST405 clonal groups. BMC Microbiol. 13: 144. Crossref |
||||
|
Palaksha MN, Ahmed M, Das S (2010). Antibacterial activity of garlic extract on streptomycin-resistant Staphylococcus aureus and Escherichia coli solely and in synergism with streptomycin. J. Nat. Sci. Biol. Med. 1: 12–15. Crossref |
||||
| Patel JB, Tenover FC, Turnidge JD, Jorgensen JH (2011). Susceptibility Test Methods: Dilution and Disk Diffusion Methods. In Versalovic et al. (eds) Manual of Clinical Microbiology. 10th edition. ASM Press, Washington DC, USA. pp. 1122-1143. | ||||
| Pillai SK, Moellering RC, Eliopoulos GM (2005). Antimicrobial Combinations. In: Antibiotics in Laboratory Medicine. Victor Lorian MD (ed) Fifth edition, Lippincott Williams, Wilkins, Philadelphia USA. pp. 365-440. | ||||
|
Ponnusamy P, Natarajan V, Sevanan M (2012). In vitro biofilm forma-tion by uropathogenic Escherichia coli and their antimicrobial susceptibility pattern. Asian Pac. J. Trop. Med. 5: 210-213. Crossref |
||||
|
Rafii F, Hansen EB Jr (1998). Isolation of nitrofurantoin-resistant mutants of nitroreductase-producing Clostridium spp. strains from the human intestinal tract. Antimicrob. Agents Chemother. 42:1121-1126. Pubmed |
||||
|
Rasmussen TB, Bjarnsholt T, Skindersoe ME, Hentzer M, Kristoffersen P, KÓ§te M., Nielsen J, Eberl L, Givskov M (2005). Screening for quorum-sensing inhibitors (QSI) by use of a novel genetic system, the QSI selector. J Bacteriol. 187:1799–1814. Crossref |
||||
|
Ross ZM, O'Gara EA, Hill DJ, Sleightholme HV, Maslin DJ (2001). Antimicrobial properties of garlic oil against human enteric bacteria: Evaluation of methodologies and comparisons with garlic oil sulfides and garlic powder. Appl. Environ. Microbiol. 67: 475–480. Crossref |
||||
|
Sandoe JA, Witherden IR, Cove JH, Heritage J, Wilcox MH (2003). Correlation between enterococcal biofilm formation in vitro and medical-device-related infection potential in vivo. J. Med. Microbiol. 52: 547–550. Crossref |
||||
|
Seno Y, Kariyama R, Mitsuhata R, Monden K, Kumon H (2005). Clinical implications of biofilm formation By Enterococcus faecalis in the urinary tract. Acta Med. Okayama 59: 79-87. Pubmed |
||||
|
Sharafadinzadeh N, Moghtaderi A, Alavi-Naini R (2008). Nitrofurantoin-induced peripheral neuropathy: A lesson to be re-learnt. Neurol. India 56: 94-96. Crossref |
||||
|
Sharma M, Aparna, Yadav S, Chaudhary U (2009). Biofilm production in uropathogenic Escherichia coli. Indian J. Pathol. Microbiol. 52:294. Crossref |
||||
|
Shuford JA, Steckelberg JM, Patel R (2005). Effects of fresh garlic extract on Candida albicans biofilms. Antimicrob. Agents Chemother. 49: 473. Crossref |
||||
|
Subramanian P, Shanmugam N, Sivaraman U, Kumar S, Selvaraj S (2012). Antiobiotic resistance pattern of biofilm-forming uropathogens isolated from catheterized patients in Pondicherry, India. Australas. Med. J. 5: 344-348. Crossref |
||||
|
Tasbakan MI, Pullukcu H, Sipahi OR, Yamazhan T, Ulusoy S (2012). Nitrofurantoin in the treatment of extended-spectrum β-lactamase-producing Escherichia coli-related lower urinary tract infection. Int. J. Antimicrob. Agents 40: 554-556. Crossref |
||||
| Teixeira L, Da Gloria M, Carvalho S, Shewmaker P, Facklam R (2011). Enterococcus. In Versalovic et al. (eds) Manual of Clinical Microbiology. 10th edition. ASM Press, Washington DC, USA. pp. 350-364. | ||||
|
Upadhyaya GP, Lingadevaru UB, Lingegowda RK (2011). Comparative study among clinical and commensal isolates of Enterococcus faecalis for presence of esp gene and biofilm production. J. Infect. Dev. Ctries. 5:365-369. Crossref |
||||
|
Wu Y, Qu W, Geng D, Liang JY, Luo YL (2012). Phenols and flavonoids from the aerial part of Euphorbia hirta. Chin. J. Nat. Med. 10:40-42. Crossref |
||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
